gland pharma glp-1 capacity india How are Indian companies making money off GLP-1? Sun Pharma, Eris to benefit

The Phase II RESCUE trial subsequently evaluated targeting the more downstream IL-6 with ziltivekimab in participants with CKD and elevated high-sensitivity CRP (hsCRP) [83]

Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

The process is relatively simple, yet effective, and can be done at Sarayu Clinics under professional supervision

What youll learn: Rybelsus is FDA-approved for type 2 diabetes, which means insurance plans are far more likely to cover it for that use than for weight loss alone

Improving the stability of chitosan-gelatin-based hydrogels for cell delivery using transglutaminase and controlled release of doxycycline

Clinical data shows glucose control becomes more variable in patients on both drugs